ZA985460B - Methods for inducing an immune response - Google Patents

Methods for inducing an immune response

Info

Publication number
ZA985460B
ZA985460B ZA985460A ZA985460A ZA985460B ZA 985460 B ZA985460 B ZA 985460B ZA 985460 A ZA985460 A ZA 985460A ZA 985460 A ZA985460 A ZA 985460A ZA 985460 B ZA985460 B ZA 985460B
Authority
ZA
South Africa
Prior art keywords
inducing
methods
immune response
immune
response
Prior art date
Application number
ZA985460A
Inventor
Guy Warner
Catherine Uyttenhove
Thierry Boon-Falleur
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of ZA985460B publication Critical patent/ZA985460B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001154—Enzymes
    • A61K39/001156—Tyrosinase and tyrosinase related proteinases [TRP-1 or TRP-2]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001186—MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA985460A 1997-06-23 1998-06-23 Methods for inducing an immune response ZA985460B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88097997A 1997-06-23 1997-06-23

Publications (1)

Publication Number Publication Date
ZA985460B true ZA985460B (en) 1999-01-26

Family

ID=25377532

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985460A ZA985460B (en) 1997-06-23 1998-06-23 Methods for inducing an immune response

Country Status (3)

Country Link
AU (1) AU7983198A (en)
WO (1) WO1998058956A2 (en)
ZA (1) ZA985460B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265215B1 (en) * 1996-09-13 2001-07-24 Ludwig Institute For Cancer Research Isolated peptides which complex with HLA-Cw16 and uses thereof
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
EP1964573B1 (en) 1999-10-22 2014-11-26 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
DE10112851C1 (en) 2001-03-16 2002-10-10 Gsf Forschungszentrum Umwelt Semi-allogeneic anti-tumor vaccine with HLA-haplo-identical antigen-presenting cells
US8921534B2 (en) 2001-12-12 2014-12-30 Sanofi Pasteur Limited Enhancement of the immune response using CD36-binding domain
MXPA05013973A (en) * 2003-06-17 2006-03-02 Mannkind Corp Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes.
JP2008503494A (en) * 2004-06-17 2008-02-07 マンカインド コーポレイション Improving the efficacy of immunotherapy by integrating diagnostic methods with therapeutic methods
EP1835932A2 (en) * 2004-12-29 2007-09-26 Mannkind Corporation Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
US7338670B2 (en) 2005-04-14 2008-03-04 Duke University Use of an agent that restores tissue perfusion and oxygenation
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
PT2486938T (en) 2006-09-26 2018-06-12 Infectious Disease Res Inst Vaccine composition containing synthetic adjuvant
EP3539567A1 (en) 2007-07-02 2019-09-18 Etubics Corporation Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
CN102272153B (en) 2008-11-24 2015-04-15 德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 High affinity t cell receptor and use thereof
TWI494125B (en) 2009-06-05 2015-08-01 Infectious Disease Res Inst Synthetic glucopyranosyl lipid adjuvants
EA034351B1 (en) 2012-05-16 2020-01-30 Иммьюн Дизайн Корп. Tricomponent vaccine for hsv-2 and methods of using same
US9605276B2 (en) 2012-08-24 2017-03-28 Etubics Corporation Replication defective adenovirus vector in vaccination
BR112015025709A2 (en) 2013-04-18 2017-07-18 Immune Design Corp gla monotherapy for cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
MD3718565T2 (en) 2015-10-22 2022-09-30 Modernatx Inc Respiratory virus vaccines
MA50335A (en) 2016-12-08 2020-08-19 Modernatx Inc NUCLEIC ACID VACCINES AGAINST RESPIRATORY VIRUSES
US11351242B1 (en) 2019-02-12 2022-06-07 Modernatx, Inc. HMPV/hPIV3 mRNA vaccine composition

Also Published As

Publication number Publication date
AU7983198A (en) 1999-01-04
WO1998058956A2 (en) 1998-12-30
WO1998058956A3 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
ZA985460B (en) Methods for inducing an immune response
EP1196192A4 (en) Method for enhancing an immune response
HUP0004034A2 (en) Kay - a novel immune system protein
GB9513261D0 (en) Vaccines
GB9717766D0 (en) Methods
EP1041891A4 (en) Roasting system
GB9704729D0 (en) Locator
GB9708918D0 (en) Methods
EP1041564A4 (en) Disk apparatus
GB9707742D0 (en) Methods
GB9718591D0 (en) Methods
GB9710820D0 (en) Immunological method
GB9807062D0 (en) Immune response
GB9503892D0 (en) An item retaining means
ZA982763B (en) Vaccines
GB2333120B (en) Suspension device
GB9822619D0 (en) Immune response stimulation
ZA985543B (en) Novel methods
GB9726147D0 (en) Antigens
GB9526433D0 (en) Vaccine component
GB9714251D0 (en) An improved cooking apparatus
GB9403718D0 (en) An item retaining means
GB9705662D0 (en) Flying device
ZA983274B (en) An ensoscopic apparatus
GB9701487D0 (en) Antigens